- NHRI technology, “Influenza vaccine production using suspension MDCK (NHRI sMDCK) cells” (abbreviated as “The Technology”) available for technology licensing.(2019/12/4)
- Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR807: a CXCR4-Targeted Antagonist”(2019/07/24)
- Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR215: A Stem Cell Mobilizer for Cell Based Therapy”(2019/07/24)
- Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR211: a peripheral CB1 receptor antagonist”（2018/12/17）
- Technology Available for Industry-Academia Collaboration or Technology Licensing. “DBPR114: a multi-targeted kinase inhibitor for solid tumors”（2018/12/13）
Patents
- 2019(until 2019/12/31)
| 獲證日 Issue date |
專利名稱 Patent Title |
證號 Patent No. |
|---|---|---|
| 2019/11/1 | Immunogenic Peptide Containing A B Cell Epitope Of Tumor Associated Antigen L6 | TWI675843 |
| 2019/9/1 | Lipidated antigen of human papillomavirus and immunotherapeutic compostion against HPV associated diseases | TWI670280 |
| 2019/8/27 | Method to enhance nerve regeneration utilizing neural stem cells and IL12p40 | US10391149 |
| 2019/8/13 | Inverted bowl shaped ultrasound probe structure of guiding the puncture needle | US10376280 |
| 2019/8/1 | Aminothiazole compounds as protein kinase inhibitors | TWI667236 |
| 2019/7/5 | Caged Platinum Nanoclusters for Anticancer Chemotherapeutics | KR101999421 |
| 2019/7/1 | Heterocyclic compounds and use thereof | TWI664174 |
| 2019/6/1 | Compositions And Methods For Enhancement Of Immune Responses | TWI660742 |
| 2019/5/28 | Aminothiazole compounds as protein kinase inhibitors | US10300061 |
| 2019/5/24 | Combination therapy for hepatitis C virus infection | CN105228619 |
| 2019/5/11 | An assessment and sleep-aid earbud with physiologic sensing and acousto-optic feedback | TWM577712 |
| 2019/5/11 | Apparatus For Combining Imaging Ultrasonic Probe And Focused Ultrasonic Probe | TWI658818 |
| 2019/5/9 | Sorbitan Polyester Conjugates for Use in Stabilizing Water-In-oil Emulsions And Delivering Controlled Release of Bioactive Agents | AU2016215757 |
| 2019/5/9 | Dipicolylamine derivatives and their pharmaceutical uses | AU2015264409 |
| 2019/5/4 | Method to enhance nerve regeneration utilizing neural stem cells and IL12p40 | CA2958398 |
| 2019/4/17 | Alpha-enolase specific antibodies and method of use in immune diseases | EP3082863 |
| 2019/4/2 | Cpg-oligodeoxynucleotide, immunogenic composition including the same, and method | US10246715 |
| 2019/4/2 | Histone deacetylase inhibitors | US10246455 |
| 2019/4/1 | Use of cationic biodegradable polyceramic | TWI654993 |
| 2019/4/1 | Device for target particle transferring and the method thereof | TWI655283 |
| 2019/3/26 | Immunosuppressant cell and production and preparation method thereof | CN104955941 |
| 2019/3/20 | Proline derivatives | EP2507232 |
| 2019/3/11 | Cpg-oligodeoxynucleotide, immunogenic composition including the same, and use of preparing medical for inducing immune response by the same | TWI653240 |
| 2019/2/28 | Use of 5-methoxytryptophan as diagnostic agent of inflammatory diseases | AU2015321470 |
| 2019/2/11 | Heterocyclic compounds and use thereof | TWI650313 |
| 2019/2/8 | Method for up-regulating and inhibiting the expression of immunoregulatory cells | JP6476299 | 2019/2/1 | Therapeutic ultrasonic device and the use thereof | TWI651109 |
| 2019/1/21 | Cell culture system for differential cyclomorphosis pulling including a sliding device, a power supply unit and a loading device | TWI648399 |
| 2019/1/21 | Sign In Other methods for reducing the life of the k-induced psychosis-like side effects and addiction disorders and compositions | TWI648049 |
| 2019/1/11 | Primer for the genotyping of M. tuberculosis, and a method for single nucleotide polymorphism marker | TWI647236 |
| 2019/1/8 | Sorbitan Polyester Conjugates for Use in Stabilizing Water-In-oil Emulsions And Delivering Controlled Release of Bioactive Agents | US10172945 |
| 2019/1/4 | Caged platinum nanocluster for anticancer chemotherapies | CN105451721 |